Catalyst Wire Dossier Catalyst Wire Dossier

mIntense L+AS 25 mg/ml Hyaluronic Acid

Hyaluronic acid · Mesoestetic Pharma Group S.L.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for mIntense L+AS 25 mg/ml Hyaluronic Acid, covering 2024-06-11 to 2024-06-11. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Performance Evaluation of mIntense L+AS 25 mg/ml Hyaluronic Acid for the Correction of Moderate to Deep Wrinkles and Folds [NA]

See pricing